0.9901
3.87%
-0.0399
Allarity Therapeutics Inc Stock (ALLR) Forecast
The Allarity Therapeutics Inc (ALLR) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $269.93, representing a +27,163% increase from the current price of $0.9901. The highest analyst price target is $272.05, and the lowest is $267.80.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ALLR Price Target
Average 218.68
(+21,987% Upside)
Is Allarity Therapeutics Inc (ALLR) A Buy Now?
Oscillators
Name | Value | Action |
---|---|---|
RSI(14) | 39.73 | Neutral |
STOCH(9,6) | 33.29 | Neutral |
STOCHRSI(14) | 66.99 | Neutral |
MACD(12,26) | -0.0878 | Buy |
ADX(14) | 22.17 | Neutral |
William %R | -79.52 | Neutral |
CCI(14) | -56.97 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
Period | Simple | Exponential |
---|---|---|
MA10 |
1.0255
Sell
|
1.0326
Sell
|
MA20 |
1.084
Sell
|
1.0936
Sell
|
MA50 |
1.3034
Sell
|
1.2174
Sell
|
MA100 |
1.193
Sell
|
1.4259
Sell
|
MA200 |
1.5527
Sell
|
3.5176
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ALLR could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on ALLR, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 39.73 indicates that ALLR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 33.29 indicates that ALLR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 66.99 indicates that ALLR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.17 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -56.97 indicates that ALLR is still oversold but not to an extreme extent.
Long-term ALLR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Allarity Therapeutics Inc financial reports and earnings history, Allarity Therapeutics Inc (ALLR) stock could reach $1,042.35 by 2030, $623.19 by 2040 and $2,372.20 by 2050. See the projected annual prices until 2050 of the Allarity Therapeutics Inc stock below:
- Allarity Therapeutics Inc (ALLR) is expected to reach an average price of $98.94 in 2035, with a high prediction of $145.76 and a low estimate of $98.96. This indicates an $9,893% rise from the last recorded price of $0.9901.
- Allarity Therapeutics Inc (ALLR) stock is projected to chart a bullish course in 2040, with an average price target of $570.60, representing an $57,530% surge from its current level. The forecast ranges from a conservative $570.60 to a sky-high $623.19.
- Our analysts predict Allarity Therapeutics Inc (ALLR) to jump 131.29K% by 2045, soaring from $1,300.88 to an average price of $1,300.88, potentially reaching $1,371.06. While $1,300.88 is the low estimate, the potential upside is significant.
- Allarity Therapeutics Inc (ALLR) stock is expected to climb by 2050, reaching an average of $2,291.81, a $231.37K% jump from its current level. However, a wide range of estimates exists, with high and low targets of $2,372.20 and $2,293.69, respectively, highlighting the market's uncertainty.
Allarity Therapeutics Inc Stock (ALLR) Year by Year Forecast
Allarity Therapeutics Inc Stock (ALLR) Price Forecast for 2025
Allarity Therapeutics Inc Stock (ALLR) is expected to reach an average price of $218.68 in 2025, with a high prediction of $272.05 and a low estimate of $165.31. This indicates an +21,987% rise from the last recorded price of $0.9901.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2025 | $266.05 | $267.80 | $272.05 | +26,771% |
February, 2025 | $257.13 | $257.13 | $253.28 | +25,870% |
March, 2025 | $244.35 | $245.40 | $244.04 | +24,579% |
April, 2025 | $248.58 | $243.86 | $246.64 | +25,007% |
May, 2025 | $241.06 | $243.82 | $241.32 | +24,247% |
June, 2025 | $232.41 | $234.84 | $237.24 | +23,373% |
July, 2025 | $221.19 | $223.07 | $226.05 | +22,240% |
August, 2025 | $211.77 | $211.97 | $214.86 | +21,289% |
September, 2025 | $199.68 | $200.40 | $208.41 | +20,068% |
October, 2025 | $190.71 | $190.81 | $196.65 | +19,162% |
November, 2025 | $179.81 | $179.86 | $185.16 | +18,061% |
December, 2025 | $165.30 | $165.31 | $176.83 | +16,595% |
Allarity Therapeutics Inc Stock (ALLR) Price Forecast for 2026
The predicted value for Allarity Therapeutics Inc (ALLR) in 2026 is set at an average of $87.08. Estimates vary from a peak of $162.36 to a trough of $11.81, indicating an +8,696% surge from the present price of $0.9901.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2026 | $147.23 | $153.68 | $162.36 | +14,771% |
February, 2026 | $139.48 | $139.61 | $144.34 | +13,987% |
March, 2026 | $128.76 | $128.77 | $135.72 | +12,905% |
April, 2026 | $114.77 | $114.80 | $125.56 | +11,491% |
May, 2026 | $103.27 | $103.36 | $111.83 | +10,330% |
June, 2026 | $91.70 | $91.73 | $100.32 | +9,162% |
July, 2026 | $77.01 | $77.04 | $88.77 | +7,678% |
August, 2026 | $65.32 | $65.34 | $73.56 | +6,497% |
September, 2026 | $50.78 | $50.81 | $62.38 | +5,028% |
October, 2026 | $39.09 | $39.10 | $47.80 | +3,848% |
November, 2026 | $27.41 | $27.44 | $36.11 | +2,668% |
December, 2026 | $11.70 | $11.81 | $24.46 | +1,082% |
Allarity Therapeutics Inc Stock (ALLR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Allarity Therapeutics Inc (ALLR) is $334.41, with a high forecast of $665.67 and a low forecast of $3.1476. This indicates an +33,675% increase from the last price of $0.9901.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2027 | $416.35 | $3.1476 | $312.20 | +41,952% |
February, 2027 | $533.04 | $473.72 | $500.84 | +53,737% |
March, 2027 | $552.02 | $507.05 | $529.28 | +55,654% |
April, 2027 | $677.66 | $631.99 | $647.21 | +68,344% |
May, 2027 | $663.31 | $664.45 | $665.67 | +66,894% |
June, 2027 | $656.73 | $652.71 | $652.28 | +66,230% |
July, 2027 | $583.93 | $591.74 | $651.22 | +58,877% |
August, 2027 | $596.87 | $596.61 | $595.39 | +60,184% |
September, 2027 | $591.35 | $593.10 | $601.59 | +59,626% |
October, 2027 | $559.14 | $569.29 | $572.97 | +56,373% |
November, 2027 | $542.34 | $547.94 | $547.85 | +54,676% |
December, 2027 | $525.09 | $523.78 | $526.06 | +52,934% |
Allarity Therapeutics Inc Stock (ALLR) Price Forecast for 2028
In 2028, Allarity Therapeutics Inc (ALLR) is projected to reach an average price of $382.57, with a high projection of $517.65 and a low estimate of $247.49. This indicates an +38,539% rise from the last price of $0.9901.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2028 | $510.21 | $511.85 | $517.65 | +51,431% |
February, 2028 | $491.34 | $493.05 | $503.64 | +49,525% |
March, 2028 | $467.45 | $470.34 | $482.64 | +47,112% |
April, 2028 | $445.77 | $446.40 | $461.72 | +44,923% |
May, 2028 | $418.05 | $418.65 | $439.07 | +42,123% |
June, 2028 | $397.82 | $397.82 | $412.31 | +40,080% |
July, 2028 | $376.60 | $377.00 | $387.62 | +37,937% |
August, 2028 | $348.42 | $348.44 | $369.03 | +35,091% |
September, 2028 | $325.09 | $325.09 | $342.50 | +32,734% |
October, 2028 | $298.28 | $298.33 | $319.12 | +30,026% |
November, 2028 | $270.24 | $270.26 | $292.31 | +27,195% |
December, 2028 | $247.18 | $247.49 | $264.28 | +24,865% |
Allarity Therapeutics Inc Stock (ALLR) Price Forecast for 2029
The 2029 price forecast for Allarity Therapeutics Inc Stock (ALLR) is $481.33 on average, with a high prediction of $955.21 and a low estimate of $7.4452. This represents an +48,514% increase from the previous price of $0.9901.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2029 | $218.96 | $219.00 | $241.41 | +22,015% |
February, 2029 | $195.65 | $195.69 | $213.08 | +19,661% |
March, 2029 | $172.27 | $172.34 | $189.78 | +17,300% |
April, 2029 | $148.77 | $148.93 | $166.39 | +14,926% |
May, 2029 | $119.52 | $119.54 | $142.88 | +11,972% |
June, 2029 | $96.11 | $96.12 | $113.65 | +9,607% |
July, 2029 | $72.71 | $72.72 | $90.22 | +7,244% |
August, 2029 | $43.48 | $43.49 | $66.82 | +4,291% |
September, 2029 | $18.86 | $19.05 | $37.61 | +1,805% |
October, 2029 | $859.33 | $7.4452 | $806.87 | +86,692% |
November, 2029 | $914.44 | $925.70 | $932.34 | +92,259% |
December, 2029 | $1,016.46 | $904.25 | $955.21 | +102.56K% |
Allarity Therapeutics Inc Stock (ALLR) Price Forecast for 2030
Allarity Therapeutics Inc Stock (ALLR) is expected to reach an average price of $871.17 in 2030, with a high forecast of $1,042.35 and a low forecast of $699.99. This signifies an +87,888% surge from the last price of $0.9901.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2030 | $1,046.68 | $1,017.46 | $1,042.35 | +105.61K% |
February, 2030 | $1,016.74 | $1,024.79 | $1,035.43 | +102.59K% |
March, 2030 | $1,007.81 | $1,010.65 | $1,004.09 | +101.69K% |
April, 2030 | $911.02 | $933.23 | $958.06 | +91,913% |
May, 2030 | $926.19 | $927.59 | $928.08 | +93,445% |
June, 2030 | $894.50 | $898.70 | $911.44 | +90,245% |
July, 2030 | $851.57 | $855.77 | $882.21 | +85,909% |
August, 2030 | $817.44 | $818.84 | $842.43 | +82,461% |
September, 2030 | $796.25 | $797.65 | $805.14 | +80,321% |
October, 2030 | $763.47 | $763.82 | $785.71 | +77,010% |
November, 2030 | $729.86 | $730.17 | $752.57 | +73,616% |
December, 2030 | $699.61 | $699.99 | $709.64 | +70,561% |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):